Vous êtes sur la page 1sur 1

Description

An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The
antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity.
Moreover, the other regulatory concerns to control the antibiotic resistance problem are also expected to drive the
antibiotics market.
The demand for antibiotics is expected to reach USD 44.68 billion by 2016. Since, 2005 this market is seen to grow
at an annual rate of 6.6% until 2011. There are many companies manufacturing antibiotic these days and there are
many other antibiotics present in the market such as aminoglycoside antibiotics and it covers about 79% of the global
demand. Moreover, the other antibiotics such as penicillin has 8%, tetracyclines 4%, erythromycin 7%, streptomycin
1% and chloramnphenicol has 1 % market share in the global antibiotic market.
There are two factors that would play an important role in the growth of the antibiotic market in the near future, i.e.,
generic competition and antibiotic resistance. The antibacterial drugs market is expected to witness restricted growth
as the patent of the major players will expire. This is the reason they are engaged in the development of anti-MRSA
treatment. Thus, new drugs are also expected to emerge in the market as a result of this. Secondly, antiobiotic
resistance is one of the major factors diminishing the popularity of these drugs and reducing its demand continuously.
The major geographies covered in this report are North America, Europe, Asia Pacific and RoW.
Some of the major players in this market are Bayer HealthCare AG, Roche,Astellas Pharma, Inc, Bristol-Myers
Squibb Co., Abbott Laboratories, MiddleBrook Pharmaceuticals, Daiichi Sankyo Company, Limited, Cubist
Pharmaceuticals, Inc., Takeda Pharmaceutical Company, Ltd Eli Lilly and Co., GlaxoSmithKline Plc, Kyorin
Pharmaceutical Co., Ltd, Johnson & Johnson, Pfizer Inc., LG Life Sciences Limited, Inc, Novartis AG, Pliva d.d.,
Sanofi-Aventis SA, and Toyama Chemical Co., Ltd.
This market research report analyzes important market segments, and major geographies. This report is a complete
study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the
coming years. It includes analysis of recent developments in technology, Porters five force model analysis and
detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the
existing market players and new entrants along with detailed value chain analysis.

About Antibiotics
Antibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria. The term
"antibiotic" is often used synonymously with antibacterial; however, the term "antibiotic" was originally
coined to refer to the antibacterial compounds of microbial origin. Antibacterial acts via various mechanisms
such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell
membrane, and the inhibition of protein synthesis. It can be bacteriostatic or bactericidal in nature.
Antibiotics are medicines that are used to treat infections caused by bacteria (e.g., respiratory tract
infections). Antibiotics work against microorganisms such as bacteria, fungi, and parasites but are not
effective against viruses. Antibiotics either block vital processes in bacteria, kill the bacteria, or halt them
from growing. Antibiotics that affect a wide range of bacteria are called broad spectrum antibiotics (e.g.,
amoxicillin and gentamicin). Antibiotics that affect only a few types of bacteria are called narrow spectrum
antibiotics (e.g., penicillin).
TechNavio's analysts forecast the Global Antibiotics market to grow at a CAGR of 1.41 percent over the period
2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Antibiotics market for the
period 20142018. To calculate the market size, the report considers the revenue generated from the sales of
various antibiotics for human use. The Global Antibiotics market can be divided into eight segments: Betalactams, Macrolides, Aminoglycosides, Phenicols, Quinolones, Sulfonamides, Tetracyclines, and Others.
TechNavio's report, the Global Antibiotics Market 2014-2018, has been prepared based on an in-depth market
analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions;
it also covers the Global Antibiotics market landscape and its growth prospects in the coming years. The
report includes a discussion of the key vendors operating in this market.